Article
Genetic variation in N-methyl-D-aspartate receptor subunit NR3A but not NR3B influences susceptibility to Alzheimer's disease.
Dementia and geriatric cognitive disorders - 1 Jan 2009
Liu Hsin-Ping, Lin Wei-Yong, Liu Shu-Hsiang, Wang Wen-Fu, Tsai Chon-Haw, Wu Bor-Tsang, Wang Chien-Kuo, Tsai Fuu-Jen
Abstract excerpt
BACKGROUND: The administration of memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has clinically improved the cognitive function of patients with Alzheimer's disease (AD), indicating that a disturbance in glutamatergic transmission might be involved in a predisposition to developing the disease. AIM: The potential association of polymorphisms in NMDA receptor subunits NR3A and NR3B, encoded by the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
